Company Filing History:
Years Active: 2006
Title: The Innovations of Carlos Miguel Sanchez Sanchez
Introduction
Carlos Miguel Sanchez Sanchez is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of vaccine development through his innovative research and patents. His work focuses on the use of recombinant defective viral genomes to enhance immune responses against infectious agents.
Latest Patents
Sanchez Sanchez holds a patent for "Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines." This patent describes vectors that comprise a recombinant defective viral genome expressing at least one antigen suitable for inducing systemic and secretory immune responses. The vectors are designed to be used in the formulation of mono- and polyvalent vaccines, particularly for various animal species, including pigs, dogs, and cats.
Career Highlights
Throughout his career, Sanchez Sanchez has been associated with Cyanamid Iberica, S.A., where he has contributed to advancements in vaccine technology. His expertise in recombinant viral genomes has positioned him as a key figure in the development of innovative solutions for infectious diseases.
Collaborations
Sanchez Sanchez has collaborated with esteemed colleagues such as Luis Enjuanes Sanchez and Juan Plana Duran. These partnerships have furthered his research and expanded the impact of his work in the scientific community.
Conclusion
Carlos Miguel Sanchez Sanchez is a pioneering inventor whose work in vaccine development has the potential to significantly improve animal health. His innovative approach to using recombinant defective viral genomes showcases the importance of research in combating infectious diseases.